Bristol Myers Squibb Reports First Quarter Financial Results for 2022
Go back to Bristol Myers Squibb Reports First Quarter Financial Results for 2022| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 62.25 -0.37 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.62 | 52 Week High | $77.12 | |||
| Open | $62.73 | 52 Week Low | $49.03 | |||
| Day High | $63.08 | P/E | 40.42 | |||
| Day Low | $62.03 | EPS | $1.54 | |||
| Volume | 13,522,383 | |||||
| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 60.97 -5.87 (8.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.84 | 52 Week High | $19.98 | |||
| Open | $67.08 | 52 Week Low | $10.52 | |||
| Day High | $68.33 | P/E | N/A | |||
| Day Low | $59.44 | EPS | $-1.45 | |||
| Volume | 3,297,639 | |||||
